Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1

NCT05960565 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT05960565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05960565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
Lead sponsor
St. Olavs Hospital
Phase
Phase 2
Overall status
Terminated
Start date
December 22, 2023
Completion date
December 22, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes